Egyptian International Pharmaceutical Industries Company reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was EGP 3,681.09 million compared to EGP 2,687.05 million a year ago. Net income was EGP 643.11 million compared to EGP 417.24 million a year ago.